BYD Company Limited
002594
Ping An Bank
000001
Cambricon
688256
4
Kweichow Moutai
600519
5
Orient Group Incorporation
600811
CN Stock MarketDetailed Quotes
000078 Shenzhen Neptunus Bioengineering
- 2.35
- -0.04-1.67%
Market Closed Feb 28 15:00 CST
6.18BMarket Cap-3.57P/E (TTM)
2.41High2.33Low179.87KlotVolume2.39Open2.39Pre Close42.58MTurnover0.69%Turnover RatioLossP/E (Static)2.63BShares3.1952wk High2.04P/B6.17BFloat Cap2.0752wk Low2.63Limit Up2.63BShs Float14.30Historical High2.15Limit Down3.35%Amplitude0.40Historical Low--Dividend TTM2.37Avg Price114.88KlotAsk--Div YieldTTM100Lot Size62.74KlotBid
Shenzhen Neptunus Bioengineering News
Neptune Biotech: Announcement on transfer of part of the accounts receivable from subsidiaries
Neptune Biotech: Announcement on the progress of transferring accounts receivable from some of its subsidiaries
Neptune Biotech: Announcement on transfer of part of the accounts receivable from subsidiaries
Neptune Biotech: Additional commitment on bill financing issues
Neptune Biotech: Voluntary Information Disclosure Notice Concerning All Payable Bonds in 2020 Have Been Repaid on Time
Neptune Biotech: Voluntary Information Disclosure Notice on Repayment of the First Issue of 2017 Interim Notes
Neptune Biotech: 2020 Tracking Rating Report for Company Entities and Related Debts
Neptune Biotech: 2017 Public Issuance of Corporate Bonds to Qualified Investors (Phase I) 2020 Principal and Interest Payment and Delisting Notice
Neptune Biotech: Announcement on Proposed Non-public Issuance of Short-Term Corporate Bonds (Epidemic Prevention and Control Bonds) Plans
Neptune Biotech: Announcement on plans to publicly issue corporate bonds (epidemic prevention and control bonds)
Neptune Biotech: 2017 Public Issuance of Corporate Bonds to Qualified Investors Second Interim Report on Fiduciary Management Matters in 2019
Neptune Biotech: Announcement on transfer of part of the accounts receivable from subsidiaries
Neptune Biotech: Announcement on the completion of 2019 interest payments on the first instalment of the 2017 medium-term notes
Neptune Biotech: 2019 Annual Tracking Rating Report for Subjects and Related Debts
Neptune Biotech: Announcement on “17 Neptune 01” investor resale results
Neptune Biotech: 2017 Public Offering of Corporate Bonds to Qualified Investors (Phase I) 2019 Interest Payment Announcement
Neptune Biotech: Announcement on “17 Neptune 01” investors' resale declarations
Neptune Biotech: Third indicative announcement on the “17 Neptune 01” coupon interest rate adjustment and investor resale implementation measures
Neptune Biotech: Second indicative announcement on the “17 Neptune 01” coupon interest rate adjustment and investor resale implementation measures
Neptune Biotech: First indicative announcement on the “17 Neptune 01” coupon interest rate adjustment and investor resale implementation measures